Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) EBT Margin (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of EBT Margin data on record, last reported at 251.47% in Q4 2025.

  • For Q4 2025, EBT Margin rose 1499.0% year-over-year to 251.47%; the TTM value through Dec 2025 reached 72.22%, up 1473.0%, while the annual FY2025 figure was 72.22%, 4300.0% up from the prior year.
  • EBT Margin reached 251.47% in Q4 2025 per PTCT's latest filing, up from 10.94% in the prior quarter.
  • Across five years, EBT Margin topped out at 251.47% in Q4 2025 and bottomed at 111.07% in Q2 2023.
  • Average EBT Margin over 5 years is 11.08%, with a median of 54.87% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 32368bps in 2022, then crashed -29093bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 83.89% in 2021, then soared by 386bps to 239.79% in 2022, then crashed by -121bps to 51.15% in 2023, then soared by 562bps to 236.48% in 2024, then increased by 6bps to 251.47% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 251.47% in Q4 2025, 10.94% in Q3 2025, and 39.72% in Q2 2025.